miR-150 promotes progressive T cell differentiation via inhibiting FOXP1 and RC3H1

Hum Immunol. 2022 Nov;83(11):778-788. doi: 10.1016/j.humimm.2022.08.006. Epub 2022 Aug 20.

Abstract

T cells used in immune cell therapy, represented by T cell receptor therapy (TCR-T), are usually activated and proliferated in vitro and are induced to a terminally differentiated phenotype, with limited viability after transfusion back into the body. T cells exhibited a robust proliferative potential and in vivo viability in the early stages of progressive differentiation. In this study, we identified microRNAs that regulate T cell differentiation. After microRNA sequencing of the four subsets: Naïve T cells (TN), stem cell-like memory T cells (TSCM), central memory T cells (TCM), and effector memory T cells (TEM), miR-150 was identified as the most highly expressed miRNA among the four subsets and was lowly expressed in the TSCM cells. We predicted the target genes of miR-150 miRNA and performed Gene Ontology and Kyoto Encyclopaedia of Genes and Genomes analyses. We observed that the target genes of miR-150 were enriched in pathways associated with T-cell differentiation. FOXP1 and RC3H1 were identified as key target genes of miR-150 in the regulation of T-cell function. We examined the effects of miR-150 on the differentiation and function of healthy donor T-cells. We observed that miR-150 overexpression promoted T-cell differentiation to effector T-cells and effector memory T-cells, enhanced apoptosis, inhibited cell proliferation and increased secretion of pro-inflammatory cytokines such as IFN-γ and TNF-α. In addition, the expressions of early differentiation-related genes (ACTN1, CERS6, BCL2, and EOMES), advanced differentiation-related genes (KLRG1), and effector-function-related genes (PRF1 and GZMB) were significantly decreased after overexpression of miR-150. Collectively, our results suggested that miR-150 can promote progressive differentiation of T cells and the downmodulation of miR-150 expression while performing adoptive immunotherapy may inhibit T-cell differentiation and increase the proliferative potential of T cells.

Keywords: Progressive differentiation; T cell; microRNA.

MeSH terms

  • Cell Differentiation / genetics
  • Cytokines / metabolism
  • Forkhead Transcription Factors / genetics
  • Forkhead Transcription Factors / metabolism
  • Humans
  • Immunologic Memory*
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Proto-Oncogene Proteins c-bcl-2
  • RNA-Binding Proteins / pharmacology
  • Receptors, Antigen, T-Cell / metabolism
  • Repressor Proteins / metabolism
  • Repressor Proteins / pharmacology
  • Tumor Necrosis Factor-alpha / metabolism
  • Ubiquitin-Protein Ligases / metabolism
  • Ubiquitin-Protein Ligases / pharmacology

Substances

  • Cytokines
  • FOXP1 protein, human
  • Forkhead Transcription Factors
  • MIRN150 microRNA, human
  • MicroRNAs
  • Proto-Oncogene Proteins c-bcl-2
  • RC3H1 protein, human
  • RNA-Binding Proteins
  • Receptors, Antigen, T-Cell
  • Repressor Proteins
  • Tumor Necrosis Factor-alpha
  • Ubiquitin-Protein Ligases